Trial of Controversial Alzheimer’s Drug Halted After Disappointing Results

Health Consultant November 26, 2024 0

Cassava Sciences said that its drug did not significantly reduce cognitive decline in 1,900 people with mild to moderate Alzheimer’s disease.

from NYT > Health https://ift.tt/pUmI5sh
via IFTTT

No comments

Subscribe to: Post Comments ( Atom )